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In the 1980s, when the production of transgenic plants
was first demonstrated and was soon followed by pro-
duction of healthy transgenic poplars in the US and
then in Belgium, many of us, including some of the
most conservation minded in forestry science, embraced
genetic engineering/genetic modification as an impor-
tant new technology for forestry. We had this sense of
following the yellow brick road to Oz. It seemed that we
could finally get beyond the narrow limitations of the
slow outbreeding, quantitative breeding system, and
begin an era of qualitative genetics to complement the
dominant quantitative genetic paradigm. Unfortunately,
when we got closer to the Wizard of Oz things looked
a bit different than on the famed Yellow Brick Road
(Figure 1).
What happened? Most important, the technology, and
how it was structured, ran into a social and political
buzz-saw. The world was becoming richer and more
sensitive, both in terms of environment and respect for
life. A diversity of social movements were taking place,
powered by the new internet, that was uncomfortable
with the notion of transgenics and who controlled them,
and a number of organizations with resources and
power opposed transgenics at every turn. A patent sys-
tem was put in place that only very large companies or
a few wealthy foundations could afford to negotiate.
Rich consumers and vulnerable consumers sensed risk
and little or no direct benefit to them, and thus also
opposed the technology in large numbers. Regulations
were pushed through that made the costs of field
research, marketing, permits, international trade, liability
insurance, and labeling huge barriers to investment and
commercial adoption. Nearly the only crops to survive
produced huge economic benefits and had to be pushed
through the regulatory system by the multinational
companies that consumers feel the least trust in.
Unfortunately, national and international regulations,
once in place, are very hard to change—so this legacy will
be with us for many years. Moreover, because the regula-
t i o n st r e a ta l lt r a n s g e n e sa sh a z a r d su n t i l“proven safe,”
they pose severe problems for conducting high quality
field trials of most types of transgenic forest trees. This is
a result of their wild and feral relatives, low level of
domestication, and ability to produce pollen and seed
that can move over large distances. Thus, it’s very hard to
integrate transgenic trees into conventional breeding and
field testing programs—which is essential for their devel-
opment and application. Meanwhile, social perspectives
and the structure of research funding has led to extraor-
dinary scrutiny and amplification of every possible risk of
transgenic trees, usually far out of proportion to its
significance compared to conventional agriculture and
forestry breeding. Thus, the trip has felt much more like
a certain Electric Kool-Aid Test (Figure 2), than a normal
technological progression, and not at all like the start of
the trip to Oz.
On the science side, despite our early successes, when
we finally got to meet the Wizard, there was also a
number of revelations that gave us pause about the
robustness of transgenic tree biotechnology, and most
r e m a i ns i g n i f i c a n tt ot h i sd a y .1 )I tw a sm u c hh a r d e rt o
transform/regenerate most commercially important for-
est tree species/genotypes than we had imagined, and
very little in the way of public research funding has
been directed to overcome this in a meaningful way. 2)
There was a great deal of hype about some of the early
successes, such as in the area of growth rate improve-
ment and lignin modification, with insufficient field
trials to judge their true merit. Many have not proven
themselves, but the results are often hidden by business
confidentiality, academic self-interest, and a paucity of
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pression for traits like herbicide and Bt-insect resistance,
the tools in place for control of gene expression were
found to be coarse, unpredictable, and imprecise, likely
due to lack of control of insertion location, chromatin
state, and poor understanding of RNAi/siRNA mechan-
isms. 4) While genetic containment would solve a lot of
social and regulatory problems, due to high social con-
cerns, short term funding, strict regulations over field
trials, and immature technology, it’s unclear if we can
attain, in the near to middle term, the nearly perfect
level of predictable, field-validated containment that
appears to be required. 5) The extraordinary advances
in genomics and phenomics in conventional breeding,
combined with the high costs of regulations, are pushing
transgenic applications to focus on the most new, novel,
and valuable applications that cannot be attained by
conventional or genome-assisted breeding—which are
also those for which attaining regulatory approval will
be most difficult. 6) Meaningful, field-based ecological
studies of fitness and non-target effects, especially of
pest-resistant, stress-resistant, bioindustrial, and biore-
mediation types of transgenic trees, have not been
conducted—leaving a wide swath for models and specu-
lations of severe ecological impact that are likely to be
vastly overstated—but push regulations toward ever
greater stringency. In sum, a great deal of fundamental
science, from the genic to the ecological, and technology
development to efficiently identify and transfer genes
and pathways, remains to be done by the next genera-
tion of scientists and practitioners.
Propelled by the ongoing successes of some pioneer-
ing companies, I sense that transgenic forest biotechnol-
ogy, though facing great difficult challenges at present,
will “keep on trucking” in the parlance of “The Trip”
(Figure 2). This will be driven by science and technology
Figure 1 On the road to transgenic Oz in the early days of plant and forest biotechnology.
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finding solutions in the face of severe global economic
and environmental problems; and the human thirst for
novelty, innovation, and truth.
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Figure 2 The trip to transgenic Oz was far risker, but also far richer and more informative about ourselves and our society, than we dard to
imagine. We will keep on working and innovating with transgenic tools, both on biological and sociopolitical fronts, because our thirst,
imagination, and world demands it.
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